Combined neutrophil-to-lymphocyte ratio and albumin-bilirubin grade predict survival in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.

Hong YM

Open source

DOI
10.1186/s12876-026-05191-9
Published
2026 Aug 12
Container
BMC gastroenterology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12876-026-05191-9,
  title = {Combined neutrophil-to-lymphocyte ratio and albumin-bilirubin grade predict survival in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.},
  author = {Hong YM},
  year = {2026},
  journal = {BMC gastroenterology},
  doi = {10.1186/s12876-026-05191-9},
  url = {https://doi.org/10.1186/s12876-026-05191-9}
}

RIS

TY  - JOUR
TI  - Combined neutrophil-to-lymphocyte ratio and albumin-bilirubin grade predict survival in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
AU  - Hong YM
PY  - 2026
JO  - BMC gastroenterology
DO  - 10.1186/s12876-026-05191-9
UR  - https://doi.org/10.1186/s12876-026-05191-9
ER  - 

APA

YM, H. (2026). Combined neutrophil-to-lymphocyte ratio and albumin-bilirubin grade predict survival in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.. BMC gastroenterology. https://doi.org/10.1186/s12876-026-05191-9

Source records